0571287 - ÚMCH 2024 RIV CH eng J - Článek v odborném periodiku
Hackbarth, S. - Gao, S. - Šubr, Vladimír - Lin, L. - Pohl, J. - Etrych, Tomáš - Fang, J.
Singlet oxygen in vivo: it is all about intensity - part 2.
Journal of Personalized Medicine. Roč. 13, č. 5 (2023), č. článku 781. E-ISSN 2075-4426
Grant CEP: GA MZd(CZ) NU21-08-00280; GA MŠMT LX22NPO5102
Institucionální podpora: RVO:61389013
Klíčová slova: photodynamic therapy * singlet oxygen * time-resolved phosphorescence
Obor OECD: Polymer science
Impakt faktor: 3, rok: 2023 ; AIS: 0.682, rok: 2023
Způsob publikování: Open access
Web výsledku:
https://www.mdpi.com/2075-4426/13/5/781DOI: https://doi.org/10.3390/jpm13050781

Recently, we reported induced anoxia as a limiting factor for photodynamic tumor therapy (PDT). This effect occurs in vivo if the amount of generated singlet oxygen that undergoes chemical reactions with cellular components exceeds the local oxygen supply. The amount of generated singlet oxygen depends mainly on photosensitizer (PS) accumulation, efficiency, and illumination intensity. With illumination intensities above a certain threshold, singlet oxygen is limited to the blood vessel and the nearest vicinity. Lower intensities allow singlet oxygen generation also in tissue which is a few cell layers away from the vessels. While all experiments so far were limited to light intensities above this threshold, we report experimental results for intensities at both sides of the threshold for the first time, giving proof for the described model. Using time-resolved optical detection in NIR, we demonstrate characteristic, illumination intensity-dependent changes in signal kinetics of singlet oxygen and photosensitizer phosphorescence in vivo. The described analysis allows for better optimization and coordination of PDT drugs and treatment, as well as new diagnostic methods based on gated PS phosphorescence, for which we report a first in vivo feasibility test.

Trvalý link: https://hdl.handle.net/11104/0344181